Inactive Instrument

Hemas Holdings Limited Stock Colombo S.E.

Equities

Consumer Goods Conglomerates

End-of-day quote Colombo S.E.
- LKR - Intraday chart for Hemas Holdings Limited
Sales 2024 * 120B 406M Sales 2025 * 132B 445M Capitalization 49.29B 166M
Net income 2024 * 6.14B 20.73M Net income 2025 * 6.55B 22.1M EV / Sales 2024 * 0.41 x
Net cash position 2024 * - 0 Net cash position 2025 * - 0 EV / Sales 2025 * 0.37 x
P/E ratio 2024 *
8.19 x
P/E ratio 2025 *
7.68 x
Employees -
Yield 2024 *
3.95%
Yield 2025 *
4.94%
Free-Float 28.67%
More Fundamentals * Assessed data
Hemas Holdings PLC Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023 CI
Hemas Holdings PLC Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023 CI
Hemas Holdings Announces Resignation of Kasturi Chellaraja, Group CEO CI
Hemas Holdings PLC Reports Earnings Results for the First Quarter Ended June 30, 2023 CI
Hemas Holdings PLC (COSE:HHL.N0000) acquired remaining 24.9% stake in Atlas Axillia Co. Ltd from Nirmal Anrudha Madanayake for LKR 3.4 billion. CI
Hemas Holdings PLC Reports Earnings Results for the Fourth Quarter Ended March 31, 2023 CI
Hemas Holdings PLC Reports Earnings Results for the Full Year Ended March 31, 2023 CI
Hemas Holdings PLC Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022 CI
Hemas Holdings PLC Announces Board Appointments, Effective January 1, 2023 CI
Hemas Holdings PLC Announces Executive Changes, Effective January 1, 2023 CI
Hemas Holdings PLC Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022 CI
Hemas Holdings PLC Reports Earnings Results for the First Quarter Ended June 30, 2022 CI
Hemas Holdings PLC Reports Earnings Results for the Full Year Ended March 31, 2022 CI
Hemas Holdings PLC Reports Earnings Results for the Fourth Quarter Ended March 31, 2022 CI
Hemas Holdings PLC Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2021 CI
More news
Managers TitleAgeSince
Chief Executive Officer - 01-12-31
Director of Finance/CFO - 23-05-31
Chairman 62 97-09-30
Members of the board TitleAgeSince
Director/Board Member - 98-08-31
Director/Board Member 72 91-04-30
Director/Board Member 64 91-04-30
More insiders
Hemas Holdings PLC is a Sri Lanka-based holding company, which is engaged in investment activities and provides advisory services to other companies in the Hemas Group. The Company’s segments include Consumer Brands, Healthcare, Mobility and Other. Consumer Brands segment offers a range of products for babies and adults in hair care, skin care, toiletries, fragrances, and oral care under the brands Kumarika, Clogard and Velvet, among others. Its brand Atlas Axillia provides school stationery and notebooks, pens, pencils, and color products. Healthcare segment is engaged in healthcare services which include pharmaceutical distribution and hospitals services under its business Hemas Hospitals, Hemas Pharmaceuticals and Morison. Mobility segment is engaged in haulage, container yard operations, warehousing, automotive logistics, transportation of project, and over-dimensional cargo services. The Company has its operations in Sri Lanka, Bangladesh, West Bengal, and Myanmar.
More about the company